Beyond Amlodipine-The Case for S-amlodipine as the First Choice Calcium Channel Blocker: An Expert Opinion from India.
S-amlodipine has antihypertensive, antianginal actions, and pleiotropic effects. S-amlodipine 2.5 mg is found to be equivalent in its efficacy and tolerability when compared to amlodipine 5 mg in the treatment of mild to moderate hypertension.
Authors
- Sarita Rao (ORCID: https://orcid.org/0009-0008-5363-8952)
- Jamshed Dalal (ORCID: https://orcid.org/0000-0001-7571-5674)
- Samir Kubba (ORCID: https://orcid.org/0000-0003-0851-4017)
- Sandeep Bansal (ORCID: https://orcid.org/0000-0002-1607-4077)
- Jagdish Hiremath
- Prakash K. Hazra
- Jagdish C. Mohan (ORCID: https://orcid.org/0000-0002-1066-5378)
- Varij Shah (ORCID: https://orcid.org/0009-0002-7691-6982)
- Jabir Abdullakutty (ORCID: https://orcid.org/0000-0002-6970-6461)
Institutions
- Apollo Hospitals (IN)
- Vardhman Mahavir Medical College & Safdarjung Hospital (IN)
- Ruby Hall Clinic (IN)
- Lourdes Hospital (IN)
- Surya Hospitals (IN)
- Jaipur Golden Hospital (IN)
- BLK Super Speciality Hospital (IN)
- Kokilaben Dhirubhai Ambani Hospital (IN)
- Apollo Hospitals (IN)
- AMRI Hospitals (IN)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-01
- DOI
- https://doi.org/10.59556/japi.73.0927
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00